Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017

Evolutionary trends in the prevalence of anti-HDV antibodies among patients positive for HBsAg referred to a national laboratory in Cameroon from 2012 to 2017

Abstract Objective The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. Results Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarka...

Full description

Bibliographic Details
Main Authors: Laurence Noubissi-Jouegouo, Marie Amougou Atsama, Paul Alain Tagnouokam-Ngoupo, Chavely Gwladys Monamele, Laure Ngono, Richard Njouom
Format: Article
Language:English
Published: BMC 2019-07-01
Series:BMC Research Notes
Subjects:
Trends
Prevalence
Anti-HDV antibodies
HBsAg
Cameroon
Online Access:http://link.springer.com/article/10.1186/s13104-019-4460-4
Description
Summary:Abstract Objective The aim of this study was to update the data on the prevalence of anti-HDV antibodies in Cameroon. Results Antibodies against hepatitis Delta virus (Anti-HDV) were found in 16.48% (95% CI 11.46–18.77%) of 426 hepatitis B virus surface antigen positive patients in Cameroon. Remarkably, they were significantly higher among people over 40 years and those living in the East and South regions of Cameroon at 66.7%, 50%, and 40%, respectively. These results suggest that older age and living in areas in the dense forest may be risk factors for Hepatitis D infection.
ISSN:1756-0500

Similar Items